Ryan J. Watts
Director, President and CEO · 1 filing · Latest: Aug 12, 2026
Denali Therapeutics Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
DNLI | Watts Ryan J. | — | Jan 6, 2026 | Proposed Sale | $16.50 | 35,198 | $580.8K | — | |
DNLI | Watts Ryan J. | — | Jul 9, 2025 | Proposed Sale | $14.33 | 495,282 | $7.1M | — | |
DNLI | Watts Ryan J. | — | Jan 7, 2025 | Proposed Sale | $20.81 | 7,650 | $159.2K | — | |
DNLI | Watts Ryan J. | — | Jan 6, 2025 | Proposed Sale | $20.22 | 29,266 | $591.7K | — | |
DNLI | RYAN WATTS | — | Oct 18, 2024 | Proposed Sale | $27.42 | 40,000 | $1.1M | — |